DUPONT CAPITAL MANAGEMENT CORP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,604,217
+13.9%
230,491
-12.7%
0.08%
-9.5%
Q3 2022$1,409,000
+123.3%
263,924
+67.0%
0.08%
+180.0%
Q2 2022$631,000
-10.1%
158,0310.0%0.03%
+7.1%
Q1 2022$702,000
+8.2%
158,031
-2.5%
0.03%
+21.7%
Q4 2021$649,000
+15.9%
162,134
+154.2%
0.02%
+27.8%
Q3 2021$560,00063,7860.02%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,009,131$7,568,0001.15%
Knoll Capital Management, LLC 124,096$931,0000.96%
683 Capital Management, LLC 1,000,000$7,500,0000.66%
Perceptive Advisors 3,085,458$23,141,0000.65%
MANGROVE PARTNERS IM, LLC 324,019$2,430,0000.16%
Stanley-Laman Group, Ltd. 64,029$480,0000.11%
WOODSTOCK CORP 67,759$508,0000.10%
Hikari Power Ltd 107,858$809,0000.10%
ARDSLEY ADVISORY PARTNERS LP 45,000$336,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 750,000$5,625,0000.01%
View complete list of ALDEYRA THERAPEUTICS INC shareholders